NCT02590757

Brief Summary

This study is a randomized controlled study to compare if a a non-invasive neurally adjusted ventilatory assist (NIV-NAVA) is better than nasal continuous positive airway pressure (N-CPAP) after extubation in infants' \< 30 weeks of gestation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2015

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 29, 2015

Completed
1 month until next milestone

Study Start

First participant enrolled

December 10, 2015

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 13, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 23, 2021

Completed
Last Updated

December 7, 2021

Status Verified

December 1, 2021

Enrollment Period

4.9 years

First QC Date

October 25, 2015

Last Update Submit

December 5, 2021

Conditions

Keywords

non-invasive ventilationnon-invasive neurally adjusted ventilatory assistnasal continuous positive airway pressure

Outcome Measures

Primary Outcomes (1)

  • Extubation failure

    Failure criteria * pH \< 7.2 with pCO2 \> 70mmHg confirmed by capillary blood gas analysis in spite of maximum settings * Severe apnea event requiring bag and mask resuscitation * FiO2 \>0.6 to maintain SpO2 ≥ 88% after extubation * Frequent desaturations (\< 85%) ≥ 3/hr not responding to increased ventilatory settings or an increase in Fio2 to 1.0

    extubation - 72 hours

Secondary Outcomes (10)

  • FiO2 >0.6 to maintain SpO2 ≥ 88% after extubation

    extubation - 72 hours

  • Severe apnea event requiring bag and mask resuscitation

    extubation - 72 hours

  • FiO2 >0.6 to maintain SpO2 ≥ 88% after extubation

    extubation - 7 days

  • pH < 7.2 with pCO2 > 70mmHg confirmed by capillary blood gas analysis in spite of maximum settings

    extubation - 7 days

  • Severe apnea event requiring bag and mask resuscitation

    extubation - 7 days

  • +5 more secondary outcomes

Study Arms (2)

NIV-NAVA

ACTIVE COMPARATOR

Noninvasive ventilation in this group is practiced with NIV-NAVA

Device: NIV-NAVA

N-CPAP

ACTIVE COMPARATOR

Patients in this group will receive nasal continuous positive airway pressure as routinely in neonatal intensive care unit.

Device: N-CPAP

Interventions

NIV-NAVADEVICE

Non-invasive neurally adjusted ventilatory assist

NIV-NAVA
N-CPAPDEVICE

Nasal-continuous positive airway pressure

N-CPAP

Eligibility Criteria

Age2 Days - 6 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • postconceptional age less than 30+0 weeks
  • infants who fulfill the the criteria for extubation for 6 hours extubation criteria: Ventilator rate ≤ 25 breaths/min, Peak inspiratory pressure (PIP) ≤ 16cmH2O, Fractional inspired oxygen (FiO2) ≤ 0.3

You may not qualify if:

  • conditions which will decrease life expectancy
  • major anomalies which will decrease life expectancy
  • any anomalous conditions which involve upper and lower airway
  • neuromuscular disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Children's Hospital

Seoul, 110-744, South Korea

Location

Related Publications (1)

  • Shin SH, Shin SH, Kim SH, Song IG, Jung YH, Kim EK, Kim HS. Noninvasive Neurally Adjusted Ventilation in Postextubation Stabilization of Preterm Infants: A Randomized Controlled Study. J Pediatr. 2022 Aug;247:53-59.e1. doi: 10.1016/j.jpeds.2022.04.025. Epub 2022 Apr 20.

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Han-Suk Kim, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Director of Neonatal Intensive Care Unit

Study Record Dates

First Submitted

October 25, 2015

First Posted

October 29, 2015

Study Start

December 10, 2015

Primary Completion

November 13, 2020

Study Completion

January 23, 2021

Last Updated

December 7, 2021

Record last verified: 2021-12

Locations